Data / Form D filings / CBA PHARMA INC
CBA PHARMA INC: Form D filings
CBA PHARMA INC, a biotechnology company in Lexington, KY, filed 5 Form D notices with the SEC between 2009 and 2015. The latest, on January 30, 2015, reports $100,000 sold of a $20 million offering to 1 investor.
Find out what CBA PHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 670 PERIMETER DR, Lexington, KY, 40517
- Phone
- (859) 266-5757
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2012
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1143410
The full lists. Form D filings in Kentucky: 216 rows, $10.80, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 30, 2015 | New notice | $20,000,000 | $100,000 | $19,900,000 | 1 | Jan 20, 2015 | sec.gov |
| Jun 6, 2013 | Amendment | $20,000,000 | $5,300,486 | $14,699,514 | 136 | Feb 13, 2012 | sec.gov |
| Feb 28, 2012 | New notice | $20,000,000 | $539,125 | $19,460,875 | 41 | Feb 13, 2012 | sec.gov |
| Apr 2, 2010 | Amendment | $10,000,000 | $3,928,115 | $6,071,885 | 149 | Mar 12, 2009 | sec.gov |
| Mar 25, 2009 | New notice | $2,000,000 | $125,000 | $1,875,000 | 4 | Mar 12, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| George P. Julius, Jr. | Executive Officer, Director | |
| Stephen P. Whitman | Executive Officer, Director | |
| Louis S. Carmichael | Executive Officer | |
| Shelden K. LeBron | Executive Officer | |
| Lawrence S. Martini | Executive Officer | |
| Robert K. Oldham, MD | Executive Officer | |
| Scott P. McKinney | Executive Officer, Director | |
| Beth Diane Gudeman | Executive Officer, Director, Promoter | |
| W. Michael Putnam | Executive Officer, Director, Promoter | |
| Robert P. Granacher, Jr., MD, MBA | Director |
Every Form D from the week of Jan 26, 2015 · All recent filings in Kentucky · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CBA PHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.